Ole Tietz
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (9)
Trans‐blood–brain barrier (BBB) delivery of therapeutic and diagnostic agents is a major challenge in the development of central nervous system (CNS) targeted radiopharmaceuticals. This review is an introduction to the use of peptides as delivery agents to transport cargos into the CNS. The most widely used BBB‐penetrating peptides are reviewed here, with a particular emphasis on the broad range of cargos delivered into the CNS using these. Cell‐penetrating peptides (CPPs) have been deployed as trans‐BBB delivery agents for some time; new developments in the CPP field offer exciting opportunities for the design of next generation trans‐BBB complexes. Many of the peptides highlighted here are ready to be combined with diagnostic and therapeutic radiopharmaceuticals to develop highly effective CNS‐targeted agents.
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Collaborators (8)
Wei-Li Kuan
Head of Biology
University of Cambridge
Abdul Karim Haji Dheere
King’s College London
MANUEL SARMIENTO SOTO
Lecturer
Universidad de Sevilla
Sarah Able
University of Oxford
Katherine Stott
University of Cambridge
Fernando Cortezon-Tamarit
University of Oxford
Lars Ittner
Macquarie University
Jessica Kwok
Associate Professor
University of Leeds
Make your next move.
Prepare your application
Review drafts before you send them.